Related Experiment Video

Updated: Nov 23, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.6K

[CD19 chimeric antigen receptor T cells therapy for relapse of acute B-lymphoblastic leukemia after transplantation]

G H Li1, X Li1, F Zhou1

  • 1Department of Hematology, NO. 960 Hospital of the Joint Service Support Force of the Chinese People's Liberation Army, Jinan 250031, China.

Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics
|January 5, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.6K
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

15.2K

Related Concept Videos